News
14m
Stockhead on MSNRise and Shine: Everything you need to know before the ASX opensGood morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today. ... Read More ...
Trump ends the de minimis exemption, halting duty-free imports globally. Chinese e-commerce giants like Shein and Temu face higher tariffs, impacting consumers.
"Something always goes wrong eventually — whether it’s a risk hiding in plain sight or something you couldn’t see coming." ...
At issue is the Trump administration's use of the International Economic Emergency Powers Act (IEEPA) to impose tariffs. The Court of Appeals heard from the Trump administration's lawyer last week ...
3h
YouTube on MSNA UNIQUE IDEA FOR YOURSELF FOR WELDERS FROM STOCK MATERIALSWelcome to my channel Mr Sagoo where you will learn how to make handmade crafts, presents, toys, and life hacks. The main ...
4h
The Manila Times on MSNInvestors to focus on inflation, GDPSECOND-QUARTER growth data, July inflation and further developments in US trade policy will likely drive market sentiment ...
On July 28, President Donald Trump’s attorneys filed an urgent motion in federal court demanding the expedited deposition of ...
On “This Week,” ABC News’ chief Washington correspondent Jonathan Karl reports on Trump’s latest tariffs, weak jobs report ...
5h
Investor's Business Daily on MSNDow Jones Futures: What To Do After Market Sell-Off. Palantir, AMD Lead Big Earnings.The stock market sold off Friday on Trump tariffs and a bad jobs report. Here's what to do. Palantir, AMD headline another ...
5h
Cryptopolitan on MSNGulf stocks drop as poor earnings and U.S. tariffs shake investor confidenceStocks in the Gulf dropped Sunday as investors responded to poor earnings and fresh economic pressure from the United States, ...
7h
India Today on MSNHow Trump tariffs could impact Indian pharma's $8.7 bn dream runIndian pharma companies will need to change tack and find newer markets should the Trump administration impose a reciprocal tariff on pharma imports ...
AbbVie ( ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results